ADS Awards, Grants & Fellowships

2021 ADS Ranji and Amara Wikramanayake Clinical Diabetes Award

2021 ADS Ranji and Amara Wikramanayake Clinical Diabetes Research Award
This Mid-Career Award supporting the career of a clinical diabetes researcher has been made possible by the generosity of Dr Ranji Wikramanayake, a long standing member of the Australian Diabetes Society.

The Australian Diabetes Society invites applications for a Mid-Career Diabetes Research Award from endocrinology/diabetes clinicians who are members of the Australian Diabetes Society (ADS) and are between 6-15 years' post-doctoral degree.  Applications can be nominated by financial members of the ADS or by self-nomination. 

The award is to recognise significant contributions to diabetes research by a clinician and to support further advancement of those achievements. 
The successful candidate will deliver the ADS Ranji and Amara Wikramanayake Clinical Diabetes Award Lecture at the 2021 ADS/ADEA Australasian Diabetes Congress that will be held at the Brisbane Convention & Exhibition Centre from Wednesday 11 to Friday 13 August 2021. In addition, the awardee will be required to provide a written report on their further achievements (projects, presentations, publications, funding, community engagement) within 18 months of accepting the award.

The award is for A$40,000 together with a commemorative plaque.

The selection criteria are:

  • Is a clinician who has provided significant contributions to diabetes research
  • Is a financial member of the ADS (Paid to 2021) for at least 12 months at the time of application
  • Is between 6-15 years post-doctoral degree
  • Is available to present the award lecture at the ADS/ADEA Australasian Diabetes Congress in 2021

Applications, accompanied by a full curriculum vitae, are now invited and should be in the form of a letter not exceeding 2 pages outlining the applicant’s suitability for the award.

Applications should be emailed to A/Professor Sof Andrikopoulos, ADS CEO at ceo@diabetessociety.com.au

Applications Closing Date: Applications have now closed

2021 ADS Lindsey Baudinet Rising Star Award in Type 1 Diabetes Research

2021 Lindsey Baudinet Rising Star Award in Type 1 Diabetes Research

The Australian Diabetes Society together with the Lindsey Baudinet Family is pleased to announce the Lindsey Baudinet Rising Star Award in Type 1 Diabetes Research.  The purpose of the award is to support eligible early-career researchers to pursue research in type 1 diabetes and its complications.

The award is $20,000 for one year.

Eligibility

To be eligible for this award, you need to:

  • Be a member of the ADS for at least 12 months at time of application
  • Be a financial member (Paid membership to 30 June 2022)
  • Be Australian-based
  • Be no more than 8 years post-doctoral at the time of application
  • Be with a mentor or in a research group/department/institute with a proven track record of supporting emerging researchers for success.
  • Be undertaking clinical or preclinical research in type 1 diabetes and its complications
  • Be an outstanding early-career researcher

Selection criteria

The selection committee will assess applicants based on:

  • Project proposal
  • CV
  • Referee reports
  • Demonstrated research excellence
  • Demonstrated financial need
  • Career aspiration

All applicants must complete the application form below (please download) to be considered for the award. Applicants will be notified at the end of June 2021.

Please download and complete the application form

Applications Closing Date: Applications have now closed

2021 Australian Diabetes Society - Lifetime Achievement Award

2021 ADS Lifetime Achievement Award

The Australian Diabetes Society invites nominations for the 2021 ADS Lifetime Achievement Award.

Eligibility
The Lifetime Achievement Award recognises an individual who has:

  1. An established history of distinguished service to education, clinical practice and/or research and training in diabetes
  2. Made a lasting contribution to diabetes
  3. Exhibited leadership and mentorship in diabetes research and/or clinical practice on a state, national and/or international level

Selection of the nominee is made on the basis of the candidate's significant, fundamental contributions to diabetes (whether in research, clinical practice, leadership, mentorship or other); the lasting impact of these contributions to the sector; and the demonstration of a lifetime commitment to diabetes.

Nominees must have:

  1. Made a positive impact to diabetes [at either state/territory or national level]
  2. The respect of professional peers
  3. General acknowledgement as having reached a pinnacle of their profession
  4. Demonstrated, over an extended period of time, a contribution which has included either research and/or clinical practice, professional leadership and service to the diabetes community
  5. Held positions of leadership
  6. Personal integrity
  7. On-going membership with the ADS

Nominees awarded the 2021 ADS Lifetime Achievement Award will be announced at the 2021 ADS Annual General Meeting.

Nomination process
Please submit two letters of recommendation including a full curriculum vitae of the nominee to the ADS CEO, Dr Sof Andrikopoulos via email: ceo@diabetessociety.com.au One letter of recommendation must be by a financial member of the ADS (Paid subs for 2021).

Nominations Closing Date: Nominations have now closed

ADS-AstraZeneca Diabetes Research Grants 2021 

ADS-AstraZeneca Diabetes Research Grants 2021

The Australian Diabetes Society (ADS) is pleased to announce a call for applications for the ADS-AstraZeneca Diabetes Research Grants 2021. Two grants will be offered and up to the value of A$20,000 each. These grants have been made possible through the generosity of AstraZeneca who have strongly supported diabetes research over many years.

Grant proposals must involve improvement of patient care and be consistent with the following identified national diabetes priorities to:

  • Reduce the prevalence and incidence of people developing type 2 diabetes
  • Promote earlier detection of diabetes
  • Reduce the occurrence of diabetes-related complications (e.g. chronic kidney disease and heart failure) and improve quality of life among people with diabetes
  • Reduce the impact of diabetes in Aboriginal and Torres Strait Islander peoples and other high risk groups
  • Strengthen prevention and care through research, evidence and data.

Projects must be applicable to diabetes care in Australia. The Principal Investigator must be a financial member (Paid membership fees to 30 June 2022) of the ADS for at least one year at the time of application. Grant applications are to be submitted in the format: title, background, aims, methods, expected contribution to patient care, project plan, ethics approval (if relevant) and a detailed budget. Grant applications must be NO longer than four A4 pages with a minimum font size of 12 (includes references). Applications must be accompanied by a full curriculum vitae. A brief report on the outcome of the work must be submitted to ADS and the awardees are expected to present their work at the 2023 Australasian Diabetes Congress (ADS/ADEA Annual Scientific Meeting) and must include acknowledgement of the Australian Diabetes Society and AstraZeneca of the grant support. 

Please note: All applications will be screened by the Grant Review Committee which will comprise members of the Australian Diabetes Society Council and external reviewers. The Grant Review Committee reserves the right to reject any application prior to review if it does not comply with the criteria or the purpose of this grant scheme. There will be no feedback provided to unsuccessful applications.

Please forward applications to:

A/Professor Sof Andrikopoulos
Chief Executive Officer
Australian Diabetes Society
Email: ceo@diabetessociety.com.au

Applications Closing Date: Thursday 30th September, 2021

2021 ADS Kellion Award

2021 ADS Kellion Award

The Kellion Foundation and the Australian Diabetes Society invite applications for the Award for an Australian who has demonstrated innovative leadership and has made an outstanding and highly original contribution to the advancement of knowledge in diabetes research, clinical or service areas in Australia.  This is an annual award that commenced in the year 2000 and is the premier award bestowed on an individual by the Australian Diabetes Society.

Nominations are now called for this Award which will be considered by a review committee consisting of the Australian Diabetes Society Council as well as prominent Australian diabetes experts and if appropriate international referees.  Nominations may be self-initiated, initiated by colleagues or by organisations.


The recipient of the ADS Kellion Award must be a financial ADS member (Paid to 2021) and a member of the society for at least 12months at time of nomination. The recipient will be required to deliver the ADS Kellion Plenary Lecture at the Australian Diabetes Society/Australian Diabetes Educators Association Australasian Diabetes Congress (ADC) that will be held at the Brisbane Convention and Exhibition Centre in QLD from Wednesday 11 to Friday 13 August 2021. The Award will include a return business class airfare to the meeting, accommodation for the duration of the meeting, full ADC registration, and a commemorative plaque. The award also includes a A$10,000 honorarium.

Nominations should include a letter (not exceeding 2 pages) clearly stating the basis of the nomination and a full curriculum vitae of the nominee.  Nominations made in the previous years have been retained and will be considered also.

Nominations Closing Date: Nominations have now closed

Please forward nominations or for further enquires to:-

Dr Sof Andrikopoulos
Chief Executive Officer
Australian Diabetes Society
Email: ceo@diabetessociety.com.au

Previous recipients of this prestigious award include:  Len Harrison (2000), Don Chisholm (2001), George Jerums (2002), Paul Zimmet (2003), Tim Welborn (2004), Mark Cooper (2005), David James (2006), Ted Kraegen (2007), Martin Silink (2008), Michael Horowitz (2009), Dennis Yue (2010), Frank Alford (2011), Joseph Proietto (2012), Peter Colman (2013), Timothy Davis (2014), Stephen Colagiuri (2015), Kerin O'Dea (2016), Mark Febbraio (2017), Jonathan Shaw (2018), Alicia Jenkins (2019), Thomas Kay (2020)

2022 ADS-Skip Martin Early Career Fellowship

This is a call for applications for a one year fellowship sponsored by the Australian Diabetes Society.
Fellowship Amount: $80,000 for one year plus a travel/conference allowance of up to $5,000.

Eligibility Criteria is as follows:

  • Applicant must be a financial ADS member (Paid membership to 30 June 2022) for at least one year at the time of application
  • The fellowship must commence by 30 June, 2022
  • The applicant must be less than 6 years post-doc as of December, 2021 (excluding career disruptions)
  • Applicant must provide a statement that the fellowship is for salary support and is not for support towards a grant/consumables.
  • Applicant must notify ADS of any fellowship applications currently pending (e.g NHMRC)
  • The fellow must take up a position in Australia for the duration of the award
  • The project must be diabetes related
  • Previous recipients of this fellowship are ineligible to re-apply

Conditions of the Fellowship include the following:

  • Award of PhD is not required at the time of application but a PhD must be awarded by the time of commencement
  • The award cannot be held in conjunction with another major fellowship. If the highest ranking applicant is successful with another fellowship application or grant providing salary support, they must notify ADS and the next suitable candidate will be offered the award
  • ADS reserves the right to not award the fellowship if there is no eligible applicant of sufficiently high standard
  • The fellow must present their work at the 2023 ADS/ADEA Australasian Diabetes Congress
  • The fellow must acknowledge the Australian Diabetes Society in publications related to the work
  • At the conclusion of the research project, the applicant must provide a report of 1-2 A4 pages outlining the outcomes of the project


Application Closing Date: Friday 8 October, 2021

To apply: Please complete the online application form below:

ADS Skip Martin Early Career Fellowship Online Application Form

We anticipate the winner will be announced in mid-November 2021.

2021 Best ADS Clinical Presentation Award in memory of Dr Paul Lee

2021 Best ADS Clinical Presentation Award in memory of Dr Paul Lee

The Best ADS Clinical Presentation Award in memory of Dr Paul Lee is to the value of A$1,250. The finalists will be categorised into Clinical Research and the award will be given to the best oral presentation by an ADS member at the ADS/ADEA Australasian Diabetes Congress that will be held at the Brisbane Convention & Exhibition Centre, QLD from Wednesday 11 to friday 13 August 2021 and judged by peer review and a committee appointed by the ADS Council. 2019 was the inaugural year of this annual award.

Eligibility is as follows:

1. A financial member of the ADS for 12 months at the time of application
(Member must have joined as a member of ADS no later than July 2020 and Paid subs for 2021)
2. Applicants must be a mid-career clinical researcher (4-10 years post-doctoral)
3. Each applicant must provide a supporting statement indicating that the work presented is substantially their own work
4. 6-8 applicants will be selected from the submitted abstracts to present in the award session
5. Previous winners of this award are in-eligible to apply
6. Finalist applicants must present work of abstract submitted for the conference; if not they will be in-eligible to receive the award

ADS ADC Awards Application Form

To apply: Please click on 'ADS ADC Awards Application Form' and complete the online application form. Please ensure that you have uploaded your supporting documentation. You must tick the box during abstract submission. Please contact Linda Valenzisi from the ADS Secretariat for any further information by email to linda@diabetessociety.com.au

Applications Closing Date: Applications have now closed

2021 ADS Australasian Diabetes Congress Registration Grants 

2021 ADS Australasian Diabetes Congress Registration Grants
This year a number of ADS Registration Grants will be awarded to junior investigators who have an abstract accepted for presentation at the 2021 ADS/ADEA Australasian Diabetes Congress that will be held as an online virtual meeting from Wednesday 11 to Friday 13 August 2021. The ADS ADC Registration Grants will be to the value of A$290 per eligible applicant. The number of grants will be determined according to the number and suitability of applications and the funds available. Applications will be prioritised using abstract review scores.

Eligibility is as follows:
1. A financial member of the ADS for 12 months at the time of application
(Applicant must have joined as a member of ADS no later than July 2020 and Paid subs for 2021)
2. In training for a higher degree eg. PhD, MD, fellowship or medical specialty
3. Supported by a statement from the candidate's supervisor or department head indicating the nature of their present position and the availability of other sources of financial support for their registration to the congress
4. Registration Grants will be made directly to the member and not their respective institution
5. Abstracts must be submitted and accepted for sessions within the ADS program only (clinical or basic science)

Note: Applicants must not be in receipt of a grant from any other body to attend the ADS/ADEA Australasian Diabetes Congress or a meeting in association with the ADS/ADEA ADC.

Applications Closing Date: Friday 23rd July, 2021


To apply: Please click on 'Apply for ADS ADC Registration Grant' below and complete the online application form and please ensure that you upload your supporting documentation. The successful applicants will be advised in writing one week prior to the congress and registration grants will be paid following the ADC. Please contact Linda Valenzisi from the ADS Secretariat for any further information by email to linda@diabetessociety.com.au

Apply for the ADS ADC Registration Grant and Upload Supporting Documentation

2021 ADS Australasian Diabetes Congress Awards

2021 ADS Australasian Diabetes Congress Awards

A number of awards and grants are available for ADS members attending the 2021 ADS/ADEA Australasian Diabetes Congress that will be held at the Brisbane Convention & Exhibition Centre, QLD from Wednesday 11 to Friday 13 August 2021.

Please ensure that you indicate (tick the appropriate boxes) during the abstract submission process via the ADC website; if you would like to be considered for any of the ADS Awards.

Please see below for all ADS ADC Awards and Grants on offer for 2021:-


ADS POSTER AWARDS

ADS Poster Awards for both Basic Science and Clinical Research will be on offer during the 2021 ADS/ADEA Australasian Diabetes Congress. ADS Poster Awards are to the value of A$500 each.

Eligibility is as follows:
1. A financial member of the ADS (Paid subs for 2021)
2. Applicants must be an early career researcher
3. You must be available to present at the time of the poster session
4. Each applicant must provide a supporting statement including one signed by his/her supervisor or department head, indicating that the work presented is substantially the candidate’s own work

To apply: Please click on 'ADS ADC Awards Application Form' and complete the online application form. Please ensure that you have uploaded your supporting documentation. You must tick the box during abstract submission. Please contact Linda Valenzisi from the ADS Secretariat for any further information by email to linda@diabetessociety.com.au

Applications Closing Date: Applications have now closed

ADS ADC Awards Application Form


ADS-PINCUS TAFT YOUNG INVESTIGATOR AWARD

The ADS-Pincus Taft Young Investigator Award is to the value of A$2000. The finalists will be categorised into Basic Science and the award will be given to the best oral presentation by a junior ADS member at the ADS/ADEA Australasian Diabetes Congress as judged by peer review and a committee appointed by the ADS Council.

Eligibility is as follows:

1. A financial member of the ADS for 12 months at the time of application
(Member must have joined as a member of ADS no later than July 2020 and Paid subs for 2021)
2. Applicants must not be more than 2 years beyond the award of a doctoral degree (PhD, MD) or fellowship (FRACP)
3. Each applicant must provide a supporting statement including one signed by his/her supervisor or department head, indicating that the work presented is substantially the candidate’s own work
4. Previous winners of this award are in-eligible to apply
5. Finalist applicants must present work of abstract submitted for the conference; if not they will be in-eligible to receive the award

6-8 applicants will be selected from abstracts to present in the ADS-Pincus Taft Young Investigators Session.

To apply: Please click on 'ADS ADC Awards Application Form' and complete the online application form. Please ensure that you have uploaded your supporting documentation. You must tick the box during abstract submission. Please contact Linda Valenzisi from the ADS Secretariat for any further information by email to linda@diabetessociety.com.au

Applications Closing Date: Applications have now closed

ADS ADC Awards Application Form


ADS PRESIDENT'S YOUNG INVESTIGATOR AWARD

The ADS President's Young Investigator Award is to the value of A$2000. The finalists will be categorised into Clinical Research and the award will be given to the best oral presentation by a junior ADS member at the ADS/ADEA Australasian Diabetes Congress as judged by peer review and a committee appointed by the ADS Council.

Eligibility is as follows:

1. A financial member of the ADS for 12 months at the time of application
(Member must have joined as a member of ADS no later than July 2020 and Paid subs for 2021)
2. Applicants must not be more than 2 years beyond the award of a doctoral degree (PhD, MD) or fellowship (FRACP)
3. Each applicant must provide a supporting statement including one signed by his/her supervisor or department head, indicating that the work presented is substantially the candidate’s own work
4. Previous winners of this award are in-eligible to apply
5. Finalist applicants must present work of abstract submitted for the conference; if not they will be in-eligible to receive the award

6-8 applicants will be selected from abstracts to present in ADS Presidents Young Investigators Session.

To apply: Please click on 'ADS ADC Awards Application Form' and complete the online application form. Please ensure that you have uploaded your supporting documentation. You must tick the box during abstract submission. Please contact Linda Valenzisi from the ADS Secretariat for any further information by email to linda@diabetessociety.com.au

Applications Closing Date: Applications have now closed

ADS ADC Awards Application Form

 

ADS-Abbott Travel Grants to ADA

ADS-Abbott Travel Grants to ADA

The Australian Diabetes Society is pleased to call for applications for the 2019 ADS-Abbott Travel Grants to attend the American Diabetes Association meeting to be held in San Francisco, California, USA from 7-11 June 2019. The merit-based travel grant will be up to the value of A$2,000 and awarded to PhD student applicants.

To be eligible, applicants must:

  • Be a financial member of the ADS (Paid 2019) for 12 months at the time of application
  • Be presenting at ADA in San Francisco (poster or oral)
  • Be a PhD or Masters student, or <1 year from submitting their PhD. Preference will be given to current students. Please include commencement date and planned thesis submission date
  • Agree to provide a written report within 2 months of the meeting for the ADS newsletter
  • Acknowledge the travel grant in their presentation

To apply, please submit:

  • A 1-page cover letter describing what benefit you expect to obtain from the meeting, and any other associated lab / other scientific visits
  • A letter of support from your supervisor
  • A short CV (maximum of 4 pages), in 12 point font, including qualifications, publications, and presentations
  • A copy of your abstract
  • A copy of the acceptance from the ADA
  • A budget, including receipts where available, and
  • A statement including ALL other sources of support and ALL other sources of pending support for attending the meeting.

The travel grant applications should be directed to Dr Sof Andrikopoulos, CEO at the Australian Diabetes Society on email ceo@diabetessociety.com.au and include the grant name in the subject line of the email.

Applications Closing Date: Applications have now closed

Applications will be peer-reviewed. The travel grant is merit based, and we reserve the right not to award the funds in this round if there are no qualifying applicants of suitable calibre.  The ADS is very grateful to Abbott Australasia for providing support of the travel grant to ADS members.

Diabetes Australia Research Program Grants for 2022

Diabetes Australia Research Program Grants for 2021

Diabetes Australia is the national organization supporting all people living with or at risk of diabetes. Diabetes Australia works in collaboration with member organisations, consumers, health professionals, researchers, and the community. 

In 2022, Diabetes Australia plans to provide vital funding for diabetes research projects across Australia, including two Millennium Awards (up to $150,000 per award) and an unspecified number of General Grants (up to $70,000 per grant).

Applications for the 2022 Grant Round are now open.

Research projects into any aspect of diabetes management or prevention will be considered. Diabetes Australia particularly encourages applications that focus on:
• self-monitoring & self-management education and support in diabetes
• Aboriginal and Torres Strait Islander people and diabetes
• behavioural and psychological research in diabetes.

Applications Closing Date: Applications have now closed


Application forms and further information are available at www.diabetesaustralia.com.au/program-management (Please click here to download the flyer

2021 ADS Jeff Flack Diabetes Data Award

2021 ADS Jeff Flack Diabetes Data Award

The Australian Diabetes Society invites nominations for the 2021 ADS Jeff Flack Diabetes Data Award for an Australian researcher who has made an outstanding contribution to Diabetes data collection in Australia. The Award will be considered by a review committee consisting of prominent Australian diabetes researchers with the option to co-opt international referees.  The nominee must be a financial member of the ADS (Paid to 2021) and have been a member for at least 12 months at the time of their nomination for this award.  At least one of the Nominator/s must be an ADS member and nominations can be self-initiated or initiated by colleagues. The award will include a A$5,000 honorarium together with a commemorative plaque.

Categories of merit include:

    • Multiple / Significant / Substantial Publications (or In Press) involving data collection, collation, analysis and reporting (beyond ‘routine day-to-day’ minimum dataset collection);
    • Something ‘Novel’ regarding data collection / reporting – development of data systems;
    • Substantial contribution to data issues (attendance / chair of Committee(s) on data issues – developing standards etc);
    • List the best 5 or 10 relevant publications;
    • Highlight all relevant publications in your CV.
Nominations should include a letter (not exceeding 2 pages) clearly stating the basis of the nomination and a full curriculum vitae and be sent to:


Dr Sof Andrikopoulos
Chief Executive Officer
Australian Diabetes Society
Email: ceo@diabetessociety.com.au 

Further enquiries can be directed to Dr Sof Andrikopoulos, CEO, ADS via email at ceo@diabetessociety.com.au

Nominations Closing Date: Nominations have now closed